225 related articles for article (PubMed ID: 34523218)
21. Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts.
Liu JC; Wang F; Xie ML; Cheng ZQ; Qin Q; Chen L; Chen R
Int J Cardiol; 2017 Feb; 228():388-393. PubMed ID: 27870967
[TBL] [Abstract][Full Text] [Related]
22. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
Friebel J; Weithauser A; Witkowski M; Rauch BH; Savvatis K; Dörner A; Tabaraie T; Kasner M; Moos V; Bösel D; Gotthardt M; Radke MH; Wegner M; Bobbert P; Lassner D; Tschöpe C; Schutheiss HP; Felix SB; Landmesser U; Rauch U
Eur Heart J; 2019 Oct; 40(40):3318-3332. PubMed ID: 31004144
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis.
Czepiel M; Diviani D; Jaźwa-Kusior A; Tkacz K; Rolski F; Smolenski RT; Siedlar M; Eriksson U; Kania G; Błyszczuk P
Cardiovasc Res; 2022 Jan; 118(2):573-584. PubMed ID: 33576779
[TBL] [Abstract][Full Text] [Related]
24. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis.
Działo E; Tkacz K; Błyszczuk P
Acta Biochim Pol; 2018; 65(3):341-349. PubMed ID: 30040870
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
27. BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca
Liu W; Wang X; Mei Z; Gong J; Huang L; Gao X; Zhao Y; Ma J; Qian L
Sci Rep; 2017 May; 7(1):1906. PubMed ID: 28507335
[TBL] [Abstract][Full Text] [Related]
28. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
29. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
[TBL] [Abstract][Full Text] [Related]
31. AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.
Cheng WS; Chen CL; Chen JT; Lin LT; Pao SI; Chen YH; Lu DW
Molecules; 2020 Sep; 25(19):. PubMed ID: 32993110
[TBL] [Abstract][Full Text] [Related]
32. WNT/β-Catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production.
Działo E; Czepiel M; Tkacz K; Siedlar M; Kania G; Błyszczuk P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576234
[TBL] [Abstract][Full Text] [Related]
33. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ
Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
[TBL] [Abstract][Full Text] [Related]
34. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts.
Lijnen P; Petrov V
Methods Find Exp Clin Pharmacol; 2002; 24(6):333-44. PubMed ID: 12224439
[TBL] [Abstract][Full Text] [Related]
36. Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease.
Choudhuri S; Garg NJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33172999
[TBL] [Abstract][Full Text] [Related]
37. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation.
Li N; Wang Z; Gao F; Lei Y; Li Z
J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691
[TBL] [Abstract][Full Text] [Related]
38. Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype.
Hall C; Law JP; Reyat JS; Cumberland MJ; Hang S; Vo NTN; Raniga K; Weston CJ; O'Shea C; Townend JN; Gehmlich K; Ferro CJ; Denning C; Pavlovic D
Sci Rep; 2023 Jul; 13(1):12137. PubMed ID: 37495732
[TBL] [Abstract][Full Text] [Related]
39. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.
Blyszczuk P; Müller-Edenborn B; Valenta T; Osto E; Stellato M; Behnke S; Glatz K; Basler K; Lüscher TF; Distler O; Eriksson U; Kania G
Eur Heart J; 2017 May; 38(18):1413-1425. PubMed ID: 27099262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
